Friday, February 10, 2006

FDA Hits ADHD Drugs in its 2/06 Meetings: Black Box Warning Urged

You can see more information on the FDA site by going here:

An FDA Committee voted yesterday that drugs used to treat attention deficit hyperactivity disorder should come with strong "black-box" warnings that they may raise the risk of heart problems in some patients.

Predictably, the drug makers said "there is no evidence cardiovascular problems occur more often in patients taking ADHD drugs than in the general population." Wow, who saw that comment coming?

The drugs are: Amphetamine/dextroamphetamine (Adderall, Adderall XR, and Dextrostat; Dexedrine and Dexedrine Spansules, methylphenidate (Concerta; Ritalin, Ritalin SR, and Ritalin LA; Methylin and Methylin ER; Metadate ER and Metadate CD, and methamphetamine (Desoxyn) and dexmethylphenidate (Focalin).

Sources for this post included the FDA site, listed above.